61 related articles for article (PubMed ID: 25835095)
1. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract][Full Text] [Related]
2. Fragment-Based NMR Screening of the BPTF PHD Finger Methyl Lysine Reader Leads to the First Small-Molecule Inhibitors.
Buchholz CR; Sneddon MS; McPherson JE; Das S; Gee CT; Grillo MJ; Chai SC; Lee RE; Chen T; Harki DA; Shelat AA; Pomerantz WCK
ACS Med Chem Lett; 2023 Oct; 14(10):1441-1447. PubMed ID: 37849548
[TBL] [Abstract][Full Text] [Related]
3. Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3).
Ayoub MC; Anderson JT; Russell BE; Wilson RB
Front Neurosci; 2023; 17():1244176. PubMed ID: 38027485
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation by ASXL1 in myeloid malignancies.
Yang FC; Agosto-Peña J
Int J Hematol; 2023 Jun; 117(6):791-806. PubMed ID: 37062051
[TBL] [Abstract][Full Text] [Related]
5. Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation.
Lin I; Wei A; Awamleh Z; Singh M; Ning A; Herrera A; ; Russell BE; Weksberg R; Arboleda VA
JCI Insight; 2023 May; 8(10):. PubMed ID: 37053013
[TBL] [Abstract][Full Text] [Related]
6. Targeted sequencing and clinical strategies in children with autism spectrum disorder: A cohort study.
Hu C; Wang Y; Li C; Mei L; Zhou B; Li D; Li H; Xu Q; Xu X
Front Genet; 2023; 14():1083779. PubMed ID: 37007974
[No Abstract] [Full Text] [Related]
7. A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review.
Yuan M; Shan Y; Xu F; Yang L; Sun C; Cheng R; Wu B; Zhang Z; Cao Y; Zhang R; Zhou W; Cheng G; Hu L
Transl Pediatr; 2023 Jan; 12(1):86-96. PubMed ID: 36798937
[TBL] [Abstract][Full Text] [Related]
8. Identifying Tissue- and Cohort-Specific RNA Regulatory Modules in Cancer Cells Using Multitask Learning.
Mokhtaridoost M; Maass PG; Gönen M
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230862
[TBL] [Abstract][Full Text] [Related]
9. ASXL1/2 mutations and myeloid malignancies.
Medina EA; Delma CR; Yang FC
J Hematol Oncol; 2022 Sep; 15(1):127. PubMed ID: 36068610
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Receptor Coregulators in Hormone-Dependent Cancers.
Jafari H; Hussain S; Campbell MJ
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626007
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Shashi-Pena Syndrome Caused by Chromosomal Rearrangement Using Nanopore Sequencing.
Wang Y; Tan J; Wang Y; Liu A; Qiao F; Huang M; Zhang C; Zhou J; Hu P; Xu Z
Neurol Genet; 2021 Dec; 7(6):e635. PubMed ID: 34841066
[TBL] [Abstract][Full Text] [Related]
12. The Role of Avapritinib for the Treatment of Systemic Mastocytosis.
Sumbly V; Landry I; Iqbal S; Bhatti Z; Alshamam MS; Ashfaq S; Rizzo V
Cureus; 2021 Sep; 13(9):e18385. PubMed ID: 34729266
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of some Acute Myeloid Leukemia - associated markers to assess their diagnostic / prognostic potential.
Mousa NO; Gado M; Assem MM; Dawood KM; Osman A
Genet Mol Biol; 2021; 44(1):e20190268. PubMed ID: 33432966
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation in the
Li JR; Huang Z; Lu Y; Ji QY; Jiang MY; Yang F
World J Clin Cases; 2020 Dec; 8(24):6465-6472. PubMed ID: 33392332
[TBL] [Abstract][Full Text] [Related]
15. Modeling Bainbridge-Ropers Syndrome in
Lichtig H; Artamonov A; Polevoy H; Reid CD; Bielas SL; Frank D
Front Physiol; 2020; 11():75. PubMed ID: 32132929
[TBL] [Abstract][Full Text] [Related]
16. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
17. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
Asada S; Kitamura T
Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
[TBL] [Abstract][Full Text] [Related]
18. Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
Papp E; Hallberg D; Konecny GE; Bruhm DC; Adleff V; Noë M; Kagiampakis I; Palsgrove D; Conklin D; Kinose Y; White JR; Press MF; Drapkin R; Easwaran H; Baylin SB; Slamon D; Velculescu VE; Scharpf RB
Cell Rep; 2018 Nov; 25(9):2617-2633. PubMed ID: 30485824
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
